(Q43415115)

23 November 2017

title

Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy (English)

1 reference

10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19900301)65:5%3C1074::AID-CNCR2820650505%3E3.0.CO;2-1

29 October 2022

1 reference

1 reference

10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19900301)65:5%3C1074::AID-CNCR2820650505%3E3.0.CO;2-1

29 October 2022

author name string

Bernstein-Singer M

5

1 reference

23 November 2017

P. S. Gill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689209

29 October 2022

M. U. Rarick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689209

29 October 2022

B. Espina

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689209

29 October 2022

C. Loureiro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689209

29 October 2022

M. Bernstein-Singer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689209

29 October 2022

B. Akil

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689209

29 October 2022

A. M. Levine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689209

29 October 2022

language of work or name

English

0 references

publication date

1 March 1990

1 reference

full work available at URL

23 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19900301)65:5%3C1074::AID-CNCR2820650505%3E3.0.CO;2-1

1 reference

10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19900301)65:5%3C1074::AID-CNCR2820650505%3E3.0.CO;2-1

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19900301)65:5%3C1074::AID-CNCR2820650505%3E3.0.CO;2-1

29 October 2022

1 reference

10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19900301)65:5%3C1074::AID-CNCR2820650505%3E3.0.CO;2-1

29 October 2022

1 reference

23 November 2017

volume

65

1 reference

23 November 2017

issue

5

1 reference

23 November 2017

page(s)

1074-1078

1 reference

Adriamycin. A new anticancer drug with significant clinical activity

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819900301%2965%3A5%3C1074%3A%3AAID-CNCR2820650505%3E3.0.CO%3B2-1

21 January 2018

Cancer Treatment Reports

2

67

531

Krigel

1983

1 reference

10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19900301)65:5%3C1074::AID-CNCR2820650505%3E3.0.CO;2-1

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.

29 October 2022

3

1 reference

10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19900301)65:5%3C1074::AID-CNCR2820650505%3E3.0.CO;2-1

A clinical review of bleomycin--a new antineoplastic agent

29 October 2022

6

1 reference

10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19900301)65:5%3C1074::AID-CNCR2820650505%3E3.0.CO;2-1

Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome

29 October 2022

9

1 reference

10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19900301)65:5%3C1074::AID-CNCR2820650505%3E3.0.CO;2-1

Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS

29 October 2022

10

1 reference

10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(19900301)65:5%3C1074::AID-CNCR2820650505%3E3.0.CO;2-1

29 October 2022

Identifiers

10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1

1 reference

23 November 2017

1 reference